Aegerolysins are relatively small proteins (15–20 kDa) with characteristic β-structural
fold. Representatives of the aegerolysin protein family are found in many taxonomic
groups; however, they are most commonly found in fungi. Despite a relatively broad
taxonomic distribution, only a few aegerolysin-like proteins have been thoroughly
researched.
The biological role of aegerolysins in fungi is still not fully elucidated. Currently, there
is only a hypothetical set of possible biological roles. According to known data, they are
likely to act during the growth and development of the organism and/or they play an
important role in the defence and survival of the organisms. Some aegerolysins are known
to have hemolytic and cytolytic activity, but in most cases that activity occurs only upon
interaction with a partner MACPF-domain protein. The ability to bind lipids has also been
observed, but the specificity of binding to a particular type of lipid varies between
representative proteins.
As part of this work, we considered four fungal aegerolysins with a specific N-terminal
extension. They are interesting mainly because of their difference from most aegerolysins
in terms of the sequence. We investigated how the N-terminal extension affects the
structure and function of aegerolysins. The results were compared to the known
aegerolysin OlyA (ostreolysin A) and to actinoporin EqtII (equinatoxin II), whose Nterminal α-helix structure significantly affects its cytolytic activity.
Using bioinformaticc analysis, we predicted and studied structural models of target
aegerolysins and some other biochemical properties. We predicted that four aegerolysins:
fusver, fusgra, phiatt, and traver have an elongated N-terminus with a predicted α-helix
structure. This is amphipathic in the case of aegerolysin fusver, fusgra, phiatt and could
potentially bind to the membrane. We prepared and purified all four aegerolysins and
showed that none of them were hemolytic, nor did they bind to different liposomes. For
the purposes of determining the structure, we tried to crystallize aegerolysins. We were
not able to achieve the aegerolysins crystallization in the selected set of crystallization
conditions.
|